A Phase II Trial of a Novel Proteasome/IMiD Combination, Ixazomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma Patients
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Dexamethasone (Primary) ; Ixazomib (Primary) ; Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 20 Jan 2017 Status changed from recruiting to withdrawn prior to enrolment as per investigator decision.
- 04 May 2016 Status changed from not yet recruiting to recruiting.
- 20 Oct 2015 New trial record